Topology Mapping of the Amino-terminal Half of Multidrug Resistance-associated Protein by Epitope Insertion and Immunofluorescence*

The multidrug resistance-associated protein (MRP) is an integral membrane protein that causes multidrug resistance when overexpressed in mammalian cells. Within the ATP-binding cassette superfamily, MRP belongs to a subgroup of structurally and functionally related proteins that includes the yeast cadmium factor 1 and yeast oligomycin resistance I proteins, and the mammalian sulfonylurea receptors SUR1 and SUR2. Hydropathy analysis of these proteins predicts a unique membrane-associated region at the amino terminus followed by a structural unit composed of 12 transmembrane (TM) domains and two nucleotide-binding domains that is characteristic of eukaryotic ATP-binding cassette transporters. The topology of the membrane-associated regions of MRP remains largely unknown and was investigated. Small hemagglutinin epitopes (YPYDVPDYAS) were inserted in predicted hydrophilic segments of the membrane-associated regions from the amino-terminal half of MRP and these proteins were expressed in HeLa cells, and tested for their capacity to confer etoposide resistance. The polarity of the inserted tags with respect to plasma membrane was then deduced by immunofluorescence in intact and permeabilized cells. Insertion of epitopes at positions 4, 163, 271, 574, and 653 produced functional proteins while insertions at positions 127, 417, 461, and 529 abrogated the capacity of MRP to confer drug resistance. Epitopes inserted at positions 4, 163, and 574 were localized extracellularly, whereas those inserted at positions 271 and 653 revealed an intracellular location. Although a single epitope inserted at position 461 was compatible with MRP function, it was inaccessible to the anti-epitope antibody and two copies of the tag at that site abrogated MRP function. These results indicate that the amino terminus of MRP is extracellular, while the linker segment joining the first and second membrane-associated regions is intracellular as is the first nucleotide-binding domain. Our findings are therefore consistent with a topological model of MRP that contains 5 TM segments in the first membrane-associated region and 6 TM segments in the second membrane region.

[1]  P. Cresswell,et al.  Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer , 1992, Nature.

[2]  S. Beverley,et al.  Heavy metal resistance: a new role for P-glycoproteins in Leishmania. , 1991, The Journal of biological chemistry.

[3]  P. Gros,et al.  Functional expression of P-glycoproteins in secretory vesicles. , 1994, The Journal of biological chemistry.

[4]  J. Walker,et al.  Distantly related sequences in the alpha‐ and beta‐subunits of ATP synthase, myosin, kinases and other ATP‐requiring enzymes and a common nucleotide binding fold. , 1982, The EMBO journal.

[5]  P. Gros,et al.  Membrane topology of P-glycoprotein as determined by epitope insertion: transmembrane organization of the N-terminal domain of mdr3. , 1995, Biochemistry.

[6]  P. Gros,et al.  Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities , 1990, Molecular and cellular biology.

[7]  V. Canfield,et al.  Transmembrane organization of the Na,K-ATPase determined by epitope addition. , 1993, Biochemistry.

[8]  G. M. Wilson,et al.  Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.

[9]  T. Elliott,et al.  Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex , 1992, Nature.

[10]  G. Tusnády,et al.  Membrane topology distinguishes a subfamily of the ATP‐binding cassette (ABC) transporters , 1997, FEBS letters.

[11]  C. Higgins,et al.  Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis* , 1997, The Journal of Biological Chemistry.

[12]  V. Gekeler,et al.  The leukotriene LTD4 receptor antagonist MK571 specifically modulates MRP associated multidrug resistance. , 1995, Biochemical and biophysical research communications.

[13]  D. Hipfner,et al.  Location of a protease-hypersensitive region in the multidrug resistance protein (MRP) by mapping of the epitope of MRP-specific monoclonal antibody QCRL-1. , 1996, Cancer research.

[14]  T. Tsuruo,et al.  Topology of P-glycoprotein as determined by epitope mapping of MRK-16 monoclonal antibody. , 1993, The Journal of biological chemistry.

[15]  I. Pastan,et al.  Biochemistry of multidrug resistance mediated by the multidrug transporter. , 1993, Annual review of biochemistry.

[16]  D. Keppler,et al.  Absence of the canalicular isoform of the MRP gene–encoded conjugate export pump from the hepatocytes in Dubin‐Johnson syndrome , 1996, Hepatology.

[17]  T. Jensen,et al.  Mapping of cystic fibrosis transmembrane conductance regulator membrane topology by glycosylation site insertion. , 1994, The Journal of biological chemistry.

[18]  D. Clarke,et al.  Membrane Topology of a Cysteine-less Mutant of Human P-glycoprotein (*) , 1995, The Journal of Biological Chemistry.

[19]  Y. Oshika,et al.  Expression of the multidrug resistance-associated protein (MRP) gene in non-small-cell lung cancer. , 1995, British Journal of Cancer.

[20]  D. Hipfner,et al.  Detection of the M(r) 190,000 multidrug resistance protein, MRP, with monoclonal antibodies. , 1994, Cancer research.

[21]  A. Duncan,et al.  Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.

[22]  P. Sonneveld,et al.  Clinical relevance of P-glycoprotein expression in haematological malignancies. , 1994, Leukemia research.

[23]  S. Cole,et al.  Biology of the multidrug resistance-associated protein, MRP. , 1996, European journal of cancer.

[24]  H. W. Veen,et al.  Handbook of Biological Physics , 1996 .

[25]  S. Cole,et al.  Structure and expression of the messenger RNA encoding the murine multidrug resistance protein, an ATP-binding cassette transporter. , 1996, Molecular pharmacology.

[26]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Keppler,et al.  cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats* , 1996, The Journal of Biological Chemistry.

[28]  D. Keppler,et al.  ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. , 1994, Cancer research.

[29]  G. Tusnády,et al.  Membrane Topology and Glycosylation of the Human Multidrug Resistance-associated Protein (*) , 1996, The Journal of Biological Chemistry.

[30]  S. Cole,et al.  Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. , 1996, The Journal of biological chemistry.

[31]  P. Borst,et al.  Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L. Tsui,et al.  Erratum: Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA , 1989, Science.

[33]  D. Hipfner,et al.  Characterization of the Mr 190,000 Multidrug Resistance Protein (MRP) in Drug-selected and Transfected Human Tumor Cells , 1995 .

[34]  M. Ouellette,et al.  The amplified H circle of methotrexate‐resistant leishmania tarentolae contains a novel P‐glycoprotein gene. , 1990, The EMBO journal.

[35]  D. Thiele,et al.  A yeast metal resistance protein similar to human cystic fibrosis transmembrane conductance regulator (CFTR) and multidrug resistance-associated protein. , 1994, The Journal of biological chemistry.

[36]  P. Bosma,et al.  Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene , 1996, Science.

[37]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[38]  N. Huskisson,et al.  Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule , 1992, Nature.

[39]  M. Voet,et al.  Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae , 1995, Molecular and cellular biology.

[40]  S. Cole,et al.  ATP-dependent 17-Estradiol 17-(-D-Glucuronide) Transport by Multidrug Resistance Protein (MRP) , 1996, The Journal of Biological Chemistry.

[41]  A. Brossi,et al.  The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance. , 1993, Biochemistry.

[42]  P. Gros,et al.  Transmembrane Organization of Mouse P-glycoprotein Determined by Epitope Insertion and Immunofluorescence (*) , 1996, The Journal of Biological Chemistry.

[43]  D. Housman,et al.  Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins , 1986, Cell.

[44]  C. Meijer,et al.  Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. , 1994, Cancer research.

[45]  D. Hipfner,et al.  Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. , 1994, Cancer research.

[46]  F. Baas,et al.  The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  A. Cowman,et al.  Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum , 1989, Cell.

[48]  M. Kool,et al.  A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin‐Johnson syndrome , 1997, Hepatology.

[49]  J. Clement,et al.  Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. , 1995, Science.

[50]  W. Dalton,et al.  P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation. , 1995, Molecular aspects of medicine.

[51]  A. Varshavsky,et al.  The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein , 1989, Nature.

[52]  D. Keppler,et al.  The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. , 1994, The Journal of biological chemistry.

[53]  J. Bryan,et al.  A Family of Sulfonylurea Receptors Determines the Pharmacological Properties of ATP-Sensitive K+ Channels , 1996, Neuron.